We’ve been so busy on the project that we’ve neglected updating the website – apologies. As of 17 November 2017:
Phase 1 has now been completed. We have gathered data from 16 sites, involving 1,326 patients and 2,008 infusions. This took considerably longer to organise and collect than we had expected, and the data had to be cleaned so it was consistent across our 16 sites, e.g. so error ratings were comparable. We have submitted two papers and have a further two in draft form. One of the highlights of this phase of the project was feeding back results to sites – we prepared a report on the data for each site and held debriefs and focus groups to discuss this at those sites. This served well to give further detail about errors and the infusion practices at each site, and some sites planned to act on the results by reviewing policy, training and purchasing equipment to help nurses in their work.
Phase 2 involves deeper observations at 5 sites involved in Phase 1. Four of these sites have been completed the fifth will commence soon. We plan to develop papers on the error inducing factors that we have observed at this stage, and the positive deviations in practices too.
Phase 3 involves reaching our to stakeholders of intravenous infusion administration. We have been disseminating our emerging findings at conferences that clinicians and hospital management have been attending throughout the project. The latter stages of phase 3 involve organising three workshops, one with manufacturers, one with NHS stakeholders and one with patients and the public. We will be organising these shortly.
The project’s steering committee and advisory groups have met several times and have provided us with great guidance and feedback throughout.
To summarise, there should be some more published findings to share soon, we have some key research activities that are still to be do, and we need to draw all of this together for the end of March 2018 – so there’s still a lot to do but we’re making great progress.
As we come to the end of Phase 1 we wanted some feedback on our emerging results and project plans. We presented analysis on 9 of our 16 sites to our Advisory Group and held breakout sessions on specific topics:
- How should we interpret the point prevalence data? What are the implications for practice/policy?
- What, if anything, do we do about the variability in practices and policies discussed in focus groups in Phase 1? How do we practically identify best practice(s)?
- How can we best disseminate our findings for maximum positive impact?
It was great to get input from the stakeholders that form our Advisory Group, which we will feed into our future project plans, reports and publications.
Research Associate: observational studies of infusion device use across multiple hospitals
Starting Salary (Grade 7), currently £33,686-34,604 inclusive of London Allowance
Applications are invited for the post of Post-doctoral Research Associate in the UCL Interaction Centre to work under the supervision of Prof. Ann Blandford and with other members of the ECLIPSE project team. The aim of the studies is to make intravenous infusion devices safer.
The successful candidate will work with clinicians and patients to run a series of observational studies on the use of infusion devices in hospitals. These will involve detailed observations in selected wards to better understand the causes and consequences of deviations from clinical protocol when delivering intravenous medications. Throughout the project, we will be working with hospital staff and policy makers to identify best practices and develop guidance on the selection and deployment of infusion devices and the delivery of infusion therapies. The postholder will also be expected to contribute to the writing of manuscripts and presentation of the data at conferences.
The post is available to start from 18th July 2016 or as soon as possible after that. The post is available until 30th June 2017 in the first instance.
Applicants should have obtained a PhD in a relevant subject (e.g., pharmacy, nursing or Human–Computer Interaction). Ideal candidates will have a strong background in qualitative research methods and experience of working in healthcare. Applicants should have demonstrated potential for excellent research (e.g., as evidenced by their publication track record in international journals) and the capability and motivation to collaborate within an interdisciplinary research group. The ability to work as part of a research team is essential.
For instructions on how to apply, and for a job description and person specification, please go to https://atsv7.wcn.co.uk/search_engine/jobs.cgi?owner=5041178&ownertype=fair&jcode=1551193. Information about the ECLIPSE project is available from http://www.eclipse.ac.uk/.
Informal enquiries about the post can be made to Professor Ann Blandford (email@example.com) or Dr Dominic Furniss (D.Furniss@ucl.ac.uk). Enquiries about the application process should be made to Dr Louise Gaynor (firstname.lastname@example.org).
Closing date for applications is Friday 10th June 2016. Interviews will be held on Monday 27th June 2016.
UCL Taking Action For Equality
We have now delivered training at four hospitals taking part in the point prevalence study and have had the pleasure of meeting many engaged and enthusiastic researchers and clinicians around the country who will be helping us with the study.
The half-day training sessions cover the study protocol, the data collection procedures and documentation, and using REDCap software for data entry. Where feasible the training has involved a practical session allowing data collectors to undertake some trial observations and get a feel for the data entry system. The data collectors have reported finding this helpful to get a better understanding of how the study will work in practice.
At each hospital those participating in the training have asked thoughtful questions, raised interesting issues for discussion and offered useful feedback, helping us to further refine our data collection tools, and improve our training materials and guidance. We are also capturing this learning in a Hints, Tips and Frequently Asked Questions sheet to ensure that each of our sites benefits from others’ experiences and ideas.
We are looking forward to further data collection at these sites, and to visiting more hospitals for training over the coming months.
We have started data collection and entry at our first site, which is going well. We have identified some interesting examples of minor deviations from local policy that have provoked debate among the ECLIPSE team regarding their significance and are highlighting the complexities of real life clinical practice.
We are using our experiences at this first site to review our data collection guidance for further sites. We are also creating a Hints, Tips & Frequently Asked Questions sheet for knowledge sharing between sites, and we’re creating a guide with examples of how to classify different discrepancies and errors to ensure consistent reporting across sites.
At our first site, we have found that our two data collectors are working together well as a team, with one recording the data on the collection forms, while the other looks at the infusions in place. When entering the data into the database, the observer who completed the forms then calls out the data and the other observer enters it. We have found this gives us a consistent approach and works well with the design of the data collection forms and the database.
Who is this workshop for?
We are looking for 10 volunteers to take part in a workshop who are:
- Over 18 years of age.
- Who either have experience of receiving medication intravenously in hospital personally OR
Who has been the parent of a child receiving medication intravenously in hospital.
What is the purpose of the workshop?
Many modern medications are delivered directly into veins (i.e. intravenously). For example, a bag of chemotherapy might be connected to a patient to treat cancer, a bag of saline might be connected and hung next to a patient for hydration, or a syringe driver might be connected to a patient for pain relief after an operation. In some cases the nurse will set these up to drip into the patient using gravity alone, and in other cases the nurse will programme a pump to control the infusion rate.
We want to hear patients’ experiences of receiving this treatment. For example: Were you given enough information? Were the pump alarms disturbing? Did you ever touch the pump yourself? What did you like and dislike about being connected to a pump? What could be improved for other patients?
This workshop aims to generate questions and review consent procedures for ECLIPSE. ECLIPSE is a research project funded by the National Institute of Health Research, which is looking to review and improve the quality and safety of intravenous infusions in hospitals.
Will my expenses be reimbursed and will my time be compensated?
You will be reimbursed expenses to attend the meeting. You will be compensated £45 for the 3 hour meeting, which will also include a buffet lunch.
When and where will the workshop take place?
The workshop will run from 12noon-3pm, Thursday 9th October 2014. It will be held at University College London, which is close to Euston Station in London.
If you are interested in taking part or just want to find out more please contact: Dominic Furniss (email@example.com)
This opportunity has also been advertised on People in Research: http://www.peopleinresearch.org/opportunity/received-intravenous-iv-medication-hospital/
The ECLIPSE project is launching on Sept 9th 2014!
Funded by the NIHR (National Institute for Healthcare Research), ECLIPSE (Exploring the Current Landscape of Intravenous Infusion Practices and Errors) aims to identify key issues related to intravenous medication errors and to develop strategies to minimise the incidence of such errors. We will conduct a national study of the frequency and types of medication errors, reviewing current practices so as to inform future strategy in purchasing, deployment and use of IV medication technology.
At the launch event we will introduce the project in more detail and Professor Nick Barber (Director of Research, Health Foundation) will be delivering a keynote talk on medication errors. There will be an opportunity for representatives from NHS trusts to ask questions about the project and to express interest in taking part in the study. We plan to work with 16 acute hospitals (including 2 children’s hospitals) and 6 oncology day care units, representing a range of practices in terms of implementation and use of drug error reduction software.
We would particularly welcome attendance by NHS staff who may be interested in participating in the study. At a national level, participants will be contributing to a project that will provide recommendations to improve patient safety across the NHS, informing the design of devices, ways of working and purchasing and policy decisions. At a local level, participating sites will gain insight into their local performance, enabling them to review and improve practices if necessary, and to make better informed decisions for future procurement, deployment and use of IV medication technology.
If you are interested in attending the event, please email Jo Iacovides (firstname.lastname@example.org) to RSVP by September 1st, or if you have any further questions.
We look forward to seeing you there!
Research Associate: observational studies of the use of infusion devices in hospitals
University College London, UCL Interaction Centre
Starting Salary (Grade 7), currently £32,699 – £39,523 per annum inclusive of London Allowance
Applications are invited for the post of Post-doctoral Research Associate in the UCL Interaction Centre (www.ucl.ac.uk/uclic) to work under the supervision of Prof. Ann Blandford and with other members of the ECLIPSE and CHI+MED project teams. The aim of the studies is to make medical devices safer. The successful candidate will work with clinicians and patients to run a series of observational studies on the use of infusion devices in hospitals. Early studies will mirror previous studies that have already taken place in the US, focusing on the prevalence and types of errors that occur with infusion devices across a range of clinical contexts. Later, in-depth studies will involve detailed observations in selected wards to better understand the causes and consequences of deviations from clinical protocol. Throughout the project, we will be working with hospital staff to identify best practices and develop guidance on the selection and deployment of infusion devices and the delivery of infusion therapies. The postholder will also be expected to contribute to the writing of manuscripts and presentation of the data at conferences.
The post is available from October 2014, for 28 months in the first instance.
Applicants should have obtained a PhD in a relevant subject (e.g., pharmacy, nursing or Human–Computer Interaction). A strong background in qualitative and quantitative research methods and experience of working in healthcare is desirable. Applicants should have demonstrated potential for excellent research (e.g., as evidenced by their publication track record in international journals) and the ability to work as part of a research team is essential.
For instructions on how to apply, and for a job description and person specification, please go to: https://atsv7.wcn.co.uk/search_engine/jobs.cgi?owner=5041178&ownertype=fair&jcode=1425886. ECLIPSE follows on from, and builds on, work in the CHI+MED project.
Informal enquiries about the post can be made to Professor Ann Blandford (email@example.com) or Dr Dominic Furniss (D.Furniss@ucl.ac.uk). Enquiries about the application process should be made to Dr Richard Young (firstname.lastname@example.org).
Closing date for applications is Wednesday 13th August 2014. Interviews will be held on 10th September 2014.
UCL Taking Action For Equality
ECLIPSE formally started yesterday. Three of the team went to an NIHR meeting to better understand expectations and management. Ethical clearance has been obtained. Do get in touch if you’d like to join us for the project launch on 9th Sept, or to be a partner in studies.
We’re making great progress on the practicalities of ECLIPSE: the contract with NIHR has been approved; the application for ethical clearance for studies is working its way through the system; the Study Steering Committee has been approved; and we have a date for our launch: Tuesday 9th September, at the School of Pharmacy, UCL. More details soon. All welcome!